The $12 billion aesthetics and cosmetic surgery sector is on the cusp of an M&A boom as the handful of young, small-cap companies in the space find themselves competing for critical mass. Bankers expect larger healthcare players to enter the market through acquisitions and also anticipate existing small-cap players may start snapping up private companies. Either way, takeout multiples are bound to go up.
To read the entire story, you must be logged in.
Please log in now or register with us.
